Literature DB >> 26058910

Changes to Pregnancy and Lactation Risk Labeling for Prescription Drugs.

Heidi Collins Fantasia, Allyssa L Harris.   

Abstract

Safe medication use by women during pregnancy and lactation is an area of concern for women and their health care providers. In December 2014, the U.S. Food and Drug Administration (FDA) issued a final rule on new labeling changes, which go into effect in June 2015 and eliminate the current letter system of A-D, X. The new labeling will include a summary of risks to using the medication during pregnancy and lactation, and supporting data and relevant information to assist health care providers in counseling pregnant and lactating women.
© 2015 AWHONN.

Entities:  

Keywords:  FDA; fetal risk; lactation; medication labeling; pregnancy

Mesh:

Substances:

Year:  2015        PMID: 26058910     DOI: 10.1111/1751-486X.12209

Source DB:  PubMed          Journal:  Nurs Womens Health        ISSN: 1751-4851


  1 in total

1.  Prescription medication use during pregnancies that resulted in births and abortions (2001-2013): A retrospective population-based study in a Canadian population.

Authors:  Christine Leong; Dan Chateau; Matthew Dahl; Jamie Falk; Alan Katz; Shawn Bugden; Colette Raymond
Journal:  PLoS One       Date:  2019-03-06       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.